{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:59:30Z","timestamp":1790841570858,"version":"4.1.0"},"reference-count":37,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To examine the course of cardiovascular autonomic neuropathy (CAN) and related cardiometabolic risk factors in patients with type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>CAN and cardiometabolic risk factors were assessed in the Danish arm of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Denmark) at 6-year (n = 777) and 13-year (n = 443) follow-up examinations. Cardiovascular autonomic reflex tests (CARTs)\u2014that is, lying to standing, deep breathing, and the Valsalva maneuver\u2014and 2-min resting heart rate variability (HRV) indices were obtained as the main measures of CAN. Risk factors related to CAN status, as determined by CARTs, were studied by using multivariate logistic regressions. The effects of risk factors on continuous CARTs and HRV indices, and their changes over time, were estimated in linear mixed models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A progressive yet heterogeneous course of CAN occurred between the 6- and 13-year follow-ups. Higher HbA1c, weight, BMI, and triglycerides were associated with prevalent CAN. No significant effect of risk factors on CARTs was found when they were analyzed as continuous variables. CART indices decreased over time, and a trend of decreasing HRV indices was seen. Higher HbA1c and BMI were associated with lower HRV index values, but these differences diminished over time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>These data confirm that hyperglycemia, obesity, and hypertriglyceridemia are negatively related to indices of CAN, although these effects diminish over time. The observed heterogeneous course of CAN may challenge the present clinical approach of categorically classifying CARTs to diagnose CAN and the notion of CAN being irreversible.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-1411","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:25:21Z","timestamp":1539195921000},"page":"2586-2594","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":91,"title":["Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark"],"prefix":"10.2337","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-3502","authenticated-orcid":false,"given":"Signe T.","family":"Andersen","sequence":"first","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Witte","sequence":"additional","affiliation":[{"name":"Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Danish Diabetes Academy, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5261-3082","authenticated-orcid":false,"given":"Jesper","family":"Fleischer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine and Medical Research Laboratory, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Lauritzen","sequence":"additional","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8356-5565","authenticated-orcid":false,"given":"Marit E.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen, Gentofte, Denmark"},{"name":"National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels S.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-1350","authenticated-orcid":false,"given":"Rodica","family":"Pop-Busui","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Charles","sequence":"additional","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"2022031301224760400_B1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.2337\/dc10-0125","article-title":"Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Pop-Busui","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2337\/dc16-1397","article-title":"Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B4","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/diacare.26.6.1895","article-title":"The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis","volume":"26","author":"Maser","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/dmrr.1239","article-title":"Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management","volume":"27","author":"Spallone","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031301224760400_B6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"2022031301224760400_B7","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.2337\/diacare.27.12.2942","article-title":"Autonomic symptoms and diabetic neuropathy: a population-based study","volume":"27","author":"Low","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.numecd.2010.07.005","article-title":"Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy","volume":"21","author":"Spallone","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2022031301224760400_B9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1464-5491.2010.03027.x","article-title":"Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications","volume":"27","author":"Ayad","year":"2010","journal-title":"Diabet Med"},{"key":"2022031301224760400_B10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2337\/diacare.27.4.972","article-title":"Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes","volume":"27","author":"Moran","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/157339907781368931","article-title":"An overview of the effect of weight loss on cardiovascular autonomic function","volume":"3","author":"Maser","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"2022031301224760400_B12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdiacomp.2010.06.001","article-title":"The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes","volume":"25","author":"Voulgari","year":"2011","journal-title":"J Diabetes Complications"},{"key":"2022031301224760400_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v9.i1.1","article-title":"Cardiac autonomic neuropathy: risk factors, diagnosis and treatment","volume":"9","author":"Serhiyenko","year":"2018","journal-title":"World J Diabetes"},{"key":"2022031301224760400_B14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031301224760400_B15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11892-014-0528-7","article-title":"Glucose control and diabetic neuropathy: lessons from recent large clinical trials","volume":"14","author":"Ang","year":"2014","journal-title":"Curr Diab Rep"},{"key":"2022031301224760400_B16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"2022031301224760400_B17","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.ijo.0801420","article-title":"The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening","volume":"24","author":"Lauritzen","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2022031301224760400_B18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00125-012-2744-5","article-title":"Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study","volume":"56","author":"Charles","year":"2013","journal-title":"Diabetologia"},{"key":"2022031301224760400_B19","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/dc13-1544","article-title":"Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study","volume":"37","author":"Sandb\u00e6k","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"2022031301224760400_B21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022031301224760400_B22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/193229680800200421","article-title":"A pocket-size device to detect autonomic neuropathy","volume":"2","author":"Ejskjaer","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"2022031301224760400_B23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/193229681200600430","article-title":"Screening for diabetic cardiac autonomic neuropathy using a new handheld device","volume":"6","author":"Gulichsen","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"2022031301224760400_B24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/193229681100500115","article-title":"Self-monitoring of cardiac autonomic function at home is feasible","volume":"5","author":"Fleischer","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"2022031301224760400_B25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology","volume":"93","year":"1996","journal-title":"Circulation"},{"key":"2022031301224760400_B26","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/dmrr.1224","article-title":"Methods of investigation for cardiac autonomic dysfunction in human research studies","volume":"27","author":"Bernardi","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031301224760400_B27","first-page":"151","article-title":"I test che valutano la risposta riflessa cardiovascolare. Neuropatia diabetica","volume":"2","author":"Cardone","year":"1990","journal-title":"Rassegna Bibliografica"},{"key":"2022031301224760400_B28","unstructured":"World Medical Association. Declaration of Helskinki: medical research involving human subjects [Internet], 2018. Available from https:\/\/www.wma.net\/what-we-do\/medical-ethics\/declaration-of-helsinki\/. Accessed 25 September 2018"},{"key":"2022031301224760400_B29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diacare.8.5.491","article-title":"The value of cardiovascular autonomic function tests: 10 years experience in diabetes","volume":"8","author":"Ewing","year":"1985","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/dc14-2459","article-title":"Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)","volume":"38","author":"Herman","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00125-008-1013-0","article-title":"Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study","volume":"51","author":"Sandbaek","year":"2008","journal-title":"Diabetologia"},{"key":"2022031301224760400_B32","first-page":"1955","article-title":"Risk-factor trajectories preceding diabetic polyneuropathy: ADDITION-Denmark","volume-title":"Diabetes Care","author":"Andersen","year":"2018"},{"key":"2022031301224760400_B33","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301224760400_B34","first-page":"94","article-title":"Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study","volume-title":"Diabetes Care","author":"Pop-Busui","year":"2017"},{"key":"2022031301224760400_B35","first-page":"1068","article-title":"Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark","volume-title":"Diabetes Care","author":"Andersen","year":"2018"},{"key":"2022031301224760400_B36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12265-012-9367-6","article-title":"What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes","volume":"5","author":"Pop-Busui","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"2022031301224760400_B37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/1932296814567226","article-title":"The degree of autonomic modulation is associated with the severity of microvascular complications in patients with type 1 diabetes","volume":"9","author":"Fleischer","year":"2015","journal-title":"J Diabetes Sci Technol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/12\/2586\/527125\/dc181411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/12\/2586\/527125\/dc181411.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T05:10:38Z","timestamp":1647148238000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/41\/12\/2586\/36615\/Risk-Factors-for-the-Presence-and-Progression-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,10,10]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-1411","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]}}}